Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Intensity Therapeutics Inc. (INTS) had Income from Continuous Operations of $-2.43M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.43M |
|
-- |
|
-- |
|
$2.53M |
|
$-2.53M |
|
$0.09M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
|
Income from Continuous Operations |
$-2.43M |
$-2.43M |
|
$-2.43M |
|
$-2.53M |
|
$-2.52M |
|
2.53M |
|
2.53M |
|
$-0.96 |
|
$-0.96 |
|
| Balance Sheet Financials | |
$10.91M |
|
-- |
|
$1.39M |
|
$12.29M |
|
$2.24M |
|
$0.07M |
|
$0.07M |
|
$2.31M |
|
$9.98M |
|
$9.98M |
|
$9.98M |
|
2.54M |
|
| Cash Flow Statement Financials | |
$-1.83M |
|
-- |
|
$0.15M |
|
$11.92M |
|
$10.24M |
|
$-1.68M |
|
$0.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.86 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.39% |
|
-24.39% |
|
-19.80% |
|
-24.22% |
|
$3.93 |
|
$-0.72 |
|
$-0.72 |
|